Category:

21 February 2023

PHARMANUTRA THE STRATEGIC GUIDELINES FOR THE NEXT YEARS WERE PRESENTED AT THE INVESTOR’S DAY

08 February 2023

PHARMANUTRA PARTNERS WITH FERRARI TO FACE THE CHALLENGES OF THE NEW LE MANS HYPERCAR 499P

24 January 2023

INTEGRATION OF THE 2023 CORPORATE EVENTS CALENDAR

12 January 2023

PUBLICATION OF THE 2023 CORPORATE EVENTS CALENDAR

04 January 2023

NEW DISTRIBUTION AGREEMENTS IN INDONESIA, KUWAIT AND MEXICO

12 December 2022

NEW COMPANY PHARMANUTRA U.S.A. CORP. ESTABLISHED FOR DISTRIBUTION IN THE UNITED STATES

05 December 2022

PHARMANUTRA S.P.A. COMPLETES AKERN S.R.L. ACQUISITION

15 November 2022

PHARMANUTRA PARTNERS WITH THE LUNA ROSSA PRADA PIRELLI TEAM FOR THE 37th EDITION OF THE AMERICA’S CUP

07 November 2022

BOARD OF DIRECTORS APPROVES INTERIM MANAGEMENT REPORT AS AT 30 SEPTEMBER 2022

15 September 2022

PHARMANUTRA S.P.A. LAUNCHES NEW PRODUCTS CETILAR® ORO AND APPORTAL® VITAL

14 September 2022

HALF-YEAR FINANCIAL REPORT AS OF 30 JUNE 2022

05 September 2022

THE BOD APPROVES THE FIRST HALF FINANCIAL REPORT AS AT 30/06/2022 AND THE GROUP’S FIRST SUSTAINABILITY REPORT

04 August 2022

BUY-BACK REPORT JULY 2022

26 July 2022

PHARMANUTRA S.P.A.: FIRST ACQUISITION CLOSING OF AKERN S.R.L. FINALISED

06 July 2022

BUY-BACK REPORT JUNE 2022

17 June 2022

GOLDEN POWER NOTIFICATION FILED IN CONNECTION WITH THE ACQUISITION OF 100% OF AKERN S.R.L.

15 June 2022

SIGNING OF THE AGREEMENT FOR THE ACQUISITION OF 100% OF AKERN S.R.L.

08 June 2022

BUY-BACK REPORT MAY 2022

27 May 2022

PUBLICATION OF THE SHAREHOLDERS’ MEETINGS MINUTES HELD ON 27/04/2022

16 May 2022

PHARMANUTRA S.P.A.: INITIATION OF SHARE BUY-BACK PROGRAM

12 May 2022

INTERIM FINANCIAL REPORT AS OF 31 MARCH 2022 NOW AVAILABLE

< 1 2 3 4 … 11 >